The Gross Margin of Suzhou Zelgen Biopharmaceuticals Co Ltd (688266.SS) is 93.06%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2023-12-31 | 93.06% |
| 2022-12-31 | 91.35% |
| 2021-12-31 | 96.71% |
| 2020-12-31 | 99.28% |
| 2019-12-31 | 32.06% |
| 2018-12-31 | 20.00% |